Evidence map›Paper›PMID 24950538›Full record

ArticleSmall GTPases2014

New insights in the regulation of Rab GTPases by G protein-coupled receptors.

Véronik Lachance, Stéphane Angers, Jean-Luc Parent

Open access · bronzeAbstract readComment
In one paragraph

Article in Small GTPases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Véronik LachanceService de Rhumatologie; Département de Médecine; Faculté de Médecine et des Sciences de la Santé; and the Institut de Pharmacologie de Sherbrooke; Université de Sherbrooke; and the Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, QC Canada.
Stéphane AngersDepartment of Pharmaceutical Sciences; Leslie Dan Faculty of Pharmacy; and the Department of Biochemistry; Faculty of Medicine; University of Toronto; Toronto, ON Canada.
Jean-Luc ParentService de Rhumatologie; Département de Médecine; Faculté de Médecine et des Sciences de la Santé; and the Institut de Pharmacologie de Sherbrooke; Université de Sherbrooke; and the Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, QC Canada.
Société Française de Rhumatologie · FRUniversité de Sherbrooke · CAUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research MOP-184095
6 · The paper itself

Abstract

Cargo-mediated regulation of vesicular transport has received great attention lately. Rab GTPases, forming the largest branch of the Ras GTPase superfamily, regulate almost every step of vesicle-mediated trafficking. Growing evidence suggests that mutations, aberrant expression, and altered post-translational modifications of Rab GTPases are associated with human diseases. However, their regulatory mechanisms and how they are connected to cargo proteins are still poorly understood. Accumulating data indicate that G protein-coupled receptors (GPCRs) directly associate with Rab GTPases and that these interactions dictate receptor trafficking. Yet, it remained unclear whether the receptors could regulate the targeting and activity of Rab GTPases in various cell compartments. It is only in recent years that experimental studies showed that GPCR signaling and interaction with Rab-associated regulatory proteins modulate the localization and activity of Rab GTPases. This research is revealing novel regulatory mechanisms of these small GTPases and should contribute to the progress in effective drug development. Recently published in the Journal of Cell Science, Lachance et al. present a novel role for ubiquitylation of Rab11a by a β2AR/HACE1 complex in regulating Rab11a activity and β2AR trafficking.

Indexed as

Protein PrenylationAlkyl and Aryl TransferasesHumansrab GTP-Binding ProteinsReceptors, Adrenergic, beta-2Ubiquitin-Protein LigasesAlkyl and Aryl Transferasesrab GTP-Binding ProteinsReceptors, Adrenergic, beta-2Ubiquitin-Protein LigasesG Protein-Coupled Receptors (GPCRs)HACE1Rab11aRab GTPasesubiquitylationvesicular traffickingβ2AR

Identifiers

PMID24950538
PMCPMC4205129
OpenAlexW1995324437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.